Clinical Trial Update: A Study to Evaluate AI-09 In Participants With Glabellar Lines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AI-09 in treating glabellar lines; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines

Drugs mentioned

• AI-09

Snippet

Sponsor: Eirion Therapeutics Inc. | Conditions: Glabellar Lines | Phase 2 | Status: ACTIVE_NOT_RECRUITING